Virtual Lymphoma Rounds: New England– May 17, 2022

Professional Education

This New England Lymphoma Rounds will be a virtual program to deliver live professional education programming during the coronavirus (COVID-19) outbreak. This program will still provide a forum for local practicing physicians from academic and community medical centers to meet and address issues specific to the diagnosis and treatment of their lymphoma patients. You will be able to tune in over the phone or online.  Please continue to check this page for updates. For updates, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation

For LRF’s official statement on COVID-19 and LRF programs and events, please click here.

Virtual Lymphoma Rounds: New England

Date: Tuesday, May 17, 2022
Time: 7:00 PM – 8:30 PM ET

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

This program is free for healthcare professionals; however, pre-registration is required.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Eva Migliore, LRF, at emigliore@lymphoma.org. Virtual Exhibit opportunities are available.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Eva Migliore (emigliore@lymphoma.org) at least one week before the program to confirm their attendance.

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

7:00 PM Welcome

Eva Migliore, Lymphoma Research Foundation

7:05 PM A 73 Year-Old Man With Fevers and Drenching Night Sweats

J. Erika Haydu, MD, PhD, Massachusetts General Hospital
Moderator: Jeremy Abramson, MD, MMSc, Massachusetts General Hospital

7:35 PM A Woman With Peripheral Vision Loss and Headache

Kevin Zhang, MD, Beth Israel Deaconess Medical Center
Moderator: Michael Leukam, MD, MS, Beth Israel Deaconess Medical Center

8:05 PM Young Patient With Bulky Localized ALK Positive Large B-cell Lymphoma

Jackson Clark, DO, University of Connecticut
Moderator: Syed Ali, MD, Saint Francis Hospital in Hartford

8:35 PM Adjourn

ABOUT THE PROGRAM
The Lymphoma Rounds program provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

This is the second program in the 2021-22 New England Rounds series.

New EnglanD Lymphoma Rounds Steering Committee

Baystate Medical Center
Armen Asik, MD
Beth Israel Deaconess Medical Center
Jon Arnason, MD
Robin Joyce, MD
Boston University School of Medicine
J. Mark Sloan, MD
Brown University School of Medicine/Rhode Island
Adam Olszewski, MD
Dana-Farber Cancer Institute
Jorge Castillo, MD
Ann LaCasce, MD, MSc
Dartmouth–Hitchcock Medical Center
Elizabeth Bengtson, MD
Erick Lansigan, MD
Lahey Hospital and Medical Center
Tarun Kewalramani, MD
Massachusetts General Hospital Cancer Center
Jeremy Abramson, MD, MSc (chair)
Jeffrey Barnes, MD, PhD
Saint Francis Hospital
Syed Ali, MD
Tufts University Cancer Center
Andreas Klein, MD
UMass Memorial Medical Center
Jan Cerny, MD, PhD, FACP
Muthalagu Ramanathan, MD
University of Vermont College of Medicine
Julian Sprague, MD, PhD
Yale University School of Medicine
Francine Foss, MD

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Lymphoma Research Foundation. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement

The University of Nebraska Medical Center designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sponsors:
Lymphoma Research Foundation and the University of Nebraska Medical Center.

This activity is supported by educational grants from: AbbVie, Inc., AstraZeneca, BTG International Inc., Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Pfizer, and TG Therapeutics